Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 465

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 465
---
 Compensation Plans (excluding securities reflected in column(A)) 
  
    Equity Compensation Plans approved by stockholders 
     7,203,307(1) 
    $8.29  
     137,218(2)
  
    Equity Compensation Plans not approved by stockholders 
     —  
     —  
     — 
  
    Total 
     7,203,307  
    $8.29  
     137,218 

(1)Consists
of shares subject to outstanding stock options, under the Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan (the “2021
Plan”), the 2019 Stock Incentive Plan (the “2019 Plan”) and INmune Bio Inc. 2017 Stock Incentive Plan (the “2017
Plan) some of which are vested and some of which remain subject to the vesting of the respective equity award.

(2)Consists
of shares available for future issuance under the 2021 Plan and the 2019 Plan.

Other

The other information required by this item will be set forth in the Proxy
Statement and is incorporated in this Annual Report by reference.

Item 13. Certain Relationships and Related
Transactions, and Director Independence

The information required by this item will be set forth in the Proxy Statement
and is incorporated in this Annal Report by reference.

Item 14. Principal Accounting Fees and Services

The information required by this item will be set forth in the Proxy Statement
and is incorporated in this Annual Report by reference.

68

PART
IV

Item
15. Exhibits.

    Exhibit No.
     
    Description of Exhibit
  
    3.1
     
    Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 filed with the SEC on August 30, 2018).

    3.2
     
    Bylaws (Incorporated by reference to Exhibit 3.2 to the Registration Statement on Form S-1 filed with the SEC on August 30, 2018).

    3.3
     
    First Amendment to the Bylaws of INmune Bio Inc. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 23, 2024).

    3.